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Hepatocyte nuclear factor 4a (HNF4a) regulates liver type fatty acid binding protein (L-FABP) gene
expression. Conversely as shown herein, L-FABP structurally and functionally also interacts with
HNF4a. Fluorescence resonance energy transfer (FRET) between Cy3-HNF4a (donor) and Cy5-L-FABP
(acceptor) as well as FRET microscopy detected L-FABP in close proximity (80 Å) to HNF4a, binding
with high afﬁnity Kd 250–300 nM. Circular dichroism (CD) determined that the HNF4a/L-FABP
interaction altered protein secondary structure. Finally, L-FABP potentiated transactivation of
HNF4a in COS7 cells. Taken together, these data suggest that L-FABP provides a signaling path to
HNF4a activation in the nucleus.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Hepatocyte nuclear factor 4a (HNF4a) is a very conserved nu-
clear receptor expressed at high level in liver hepatocytes but also
in small intestine, colon, pancreatic beta cells, and kidney proximal
tubules. HNF4a controls expression of multiple hepatic genes in-
volved in lipid and glucose homeostasis, especially the cytosolic
long chain fatty acid LCFA/LCFA-CoA binding proteins liver-type
fatty acid binding protein (L-FABP) and acyl-CoA binding protein
(ACBP) [1–4]. In a positive feed-back mechanism, ACBP directly
binds and activates HNF4a transcriptional activity [5]. Unknown
is whether L-FABP likewise interacts with HNF4a to impact
transcription.
Resolving potential contributions of L-FABP to HNF4a regula-
tion is important since mutations, whether in the HNF4a binding
site or in the gene itself, are directly linked to human disease,
especially monogenic non-insulin-dependent diabetes mellitus
type II (MODY1) [6]. Indirectly, HNF4a has also been linked to
human disease through regulation of other genes contributing todiabetes (via PEPCK, L-PK, and HNF1), atherosclerosis, thrombosis,
hypoxia, MCAD deﬁciency, OTC deﬁciency, and cancer [7–9].
The present study begins to address the question of whether
L-FABP interacts with and activates HNF4a analogous to ACBP
binding/activating HNF4a [5] and L-FABP binding/activating per-
oxisome proliferator activated receptor-a (PPARa) [10–12]. As
shown by ﬂuorescence resonance energy transfer (FRET), FRET
binding assay, circular dichroism, and transactivation as well as
laser scanning confocal microscopy (LSCM) FRET, L-FABP structurally
and functionally bound HNF4a to stimulate HNF4a transcriptional
activity in the presence of known ligands of each protein.2. Materials and methods
2.1. Chemicals
Bezaﬁbrate was from Santa Cruz Biotechnology (Dallas, TX)
while 2-bromopalmitic, palmitic, and arachidonic acid as well as
b-galactosidase were from Sigma–Aldrich (St. Louis, MO).
Non-hydrolyzable C16:0-S-S-CoA was prepared as in [13].
2.2. Expression and puriﬁcation of recombinant rat L-FABP and HNF4a
The full-length rat L-FABP and HNF4a recombinant proteins
were obtained and puriﬁed as described [10,14,15]. Protein purity
was determined by SDS–PAGE and concentrations were deter-
mined by BCA Protein Assay (Pierce, Rockford, IL).
Fig. 1. FRET detection of L-FABP/HNF4a interaction in vitro. HNF4a and L-FABP
proteins were labeled with Cy3 and Cy5, respectively, spectra obtained, and binding
curves calculated from FRET observed as Cy3 (donor) ﬂuorophore quenching and
Cy5 (acceptor) sensitized emission as in Methods. (A) Emission spectra of Cy3-
HNF4a in absence (spectrum 1) and presence of increasing Cy5-L-FABP up to
1500 nM (spectrum 14). Inset: Plot of Cy3-HNF4a peak ﬂuorescence at 570 nm
(solid circles) and ﬁtted ligand binding curve (solid line). (B) Scaled portion of the
spectra near 680 nm in (A) showing Cy5-L-FABP sensitized emission resulted from
FRET from donor Cy3-HNF4a. Inset: Plot of Cy5-L-FABP sensitized emission at
680 nm (solid circles) and ﬁtted ligand binding curve (solid line). (C) Emission
spectra of Cy3-b-galactosidase without or with increasing Cy5-L-FABP showing
little to no quenching. Inset: enlarged spectra of the Cy5-L-FABP sensitized emission
near 680 nm showing no sensitized emission.
Table 1
FRET determination of intermolecular distance and binding afﬁnity between L-FABP/HN
calculated from Cy3-HNF4a quenching and Cy5-L-FABP sensitized emission spectra in Fig
Interacting proteins Cy3 quenching
Kd (nM) E (%)
Cy3-HNF4a + Cy5-L-FABP 250 ± 50 16 ± 2
Cy3-b-galactosidase + Cy5-L-FABP >10000 <1
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HNF4aCy5-L-FABP: intermolecular distance and binding afﬁnity
Puriﬁed recombinant HNF4a and L-FABP were labeled with the
ﬂuorophores Cy3 and Cy5, respectively, to form a FRET donor–
acceptor pair for determining intermolecular distance and binding
afﬁnities as described earlier [5,10,11].
2.4. LSCM FRET imaging of L-FABP/HNF4a interaction in cultured T-7
rat hepatoma cells
T-7 cells were grown to near 80% conﬂuency in 4-well LabTek
chambered slides, ﬁxed and labeled with primary antibodies to
HNF4a and L-FABP followed by secondary antibodies conjugated
with FITC, Cy3, and Cy5, respectively. Cells were imaged by LCSM
using a Bio-Rad MRC-1024 (Zeiss, Inc, Thornwood, NY) equipped
with anAr+/Kr+ laser as described [5]. Detector gain and black levels
were adjusted to minimize autoﬂuorescence and excitation was at
sufﬁcient lowpowerspreventbleed through into theother channels.
2.5. Circular dichroism (CD) of L-FABP/HNF4a complex
Far UV CD spectra of recombinant L-FABP and full-length
HNF4a, separately and in combination were obtained as described
[5,10]. Percentage composition of helixes, b-strands, turns and ran-
dom coil was calculated as described therein. Controls were run for
buffer alone in the absence of protein and spectra subtracted from
protein-containing sample spectra. Theoretical CD spectra (no
interaction) were calculated from HNF4a and L-FABP experimental
CD spectra as in [5,10].
2.6. Functional consequence of L-FABP/HNF4a interaction:
transactivation assay
Transactivation assay was performed as described earlier ex-
cept that COS-7 cells (ATCC, Manassas, VA) were transfected with
pcDNA3-L-FABP instead of an ACBP expressing vector [5]. The
ApoBLuc reporter plasmid and pLEN4S HNF4a expression vector
were from Dr. F. Sladek (University of California, Riverside, CA).
Cells were washed twice, incubated in serum free medium for
2 h, 10 lM of lipidic ligand/BSA complex added, incubated over-
night, and assayed as in [5]. Data was presented as ﬁreﬂy luciferase
activity normalized to Renilla luciferase activity and corrected for
effect of empty pLEN4 vector, with the L-FABP-bezaﬁbrate sample
arbitrarily set to 100%.
2.7. Statistical analysis
Statistical analysis on the data was performed using either a
t-test or by one-way ANOVA using statistical software (GraphPad
Prism, San Diego, CA). Values represent the mean ± S.E.M., with
P < 0.05 considered statistically signiﬁcant.F4a. Intermolecular distance and binding afﬁnity (Kd, dissociation constant) were
. 1.
Cy5 sensitized emission
r (Å) Kd (nM) E (%) r (Å)
70 ± 10 300 ± 150 6 ± 2 80 ± 20
>>100 >10000 <1 >>100
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3.1. FRET between puriﬁed Cy3-HNF4a and Cy5-L-FABP
Cy3- and Cy5-form effective FRET donor–acceptor pairs for
determining intermolecular distance and binding afﬁnity
[5,10,11]. With increasing Cy5-L-FABP (acceptor), strong quench-
ing (Fig. 1A) and saturable binding (Fig. 1A inset-solid circles) to
Cy3-HNF4a were observed. Likewise, with increasing Cy5-L-FABP
(acceptor), increasing sensitized emission of Cy5-L-FABP (Fig. 1B)
and saturable binding (Fig. 1B inset-solid circles) to Cy3-HNF4a
were observed. Nonlinear regression analysis of the binding curves
(Fig. 1A and B solid lines) yielded Kds of 250 ± 50 nM and
300 ± 150 nM, respectively (Table 1). The mean FRET interaction
distances was r = 70 ± 10 Å and 80 ± 20 Å, respectively (Table 1).
Control Cy3-labeled b-galactosidase was similarly titrated with
Cy5-L-FABP, but Cy3- emission was only weakly quenched
(Fig. 1C), sensitized emission from Cy5 did not appear (Fig. 1C
inset), and saturable binding curves were not obtained (not
shown). Thus, Cy3-HNF4a/Cy5-L-FABP FRET was not due to
random distribution of Cy3 and Cy5 ﬂuorophores or diffusion-
enhanced effects.3.2. Circular dichroism (CD) detected altered secondary structure on L-
FABP/HNF4a binding
Coregulator induced conformational changes in nuclear
receptors such as HNF4a and PPARa are crucial to receptor
activation [5,10,11]. To determine if L-FABP/HNFa interaction
altered conformation, CD spectra were acquired for HNF4a alone
(Fig. 2A circles), L-FABP alone (Fig. 2A triangles), and HNF4a and
L-FABP together (Fig. 2A squares). A theoretical CD spectrum (no
interaction, Fig. 2A, diamonds) was calculated from HNF4a and
L-FABP experimental CD spectra as described in Methods. L-FABP
and HNF4a differed signiﬁcantly in the percentage of a-helix,
b-strand, turns, and unordered secondary structure (Fig. 2B, C
and D). While L-FABP/HNFa interaction did not alter the
proportions of a-helical structures from non-interacting (Fig. 2B,
gray vs. dark gray bars), the proportions of regular b-sheet and
total b-sheet (Fig. 2C) were signiﬁcantly decreased while
unordered structure (Fig. 2D) was increased as compared to non-
interacting.Fig. 2. CD detection of conformational alterations in L-FABP/HNF4a complex. (A)
CD spectra, converted to molar ellipticity, of recombinant rat L-FABP (triangles) and
HNF4a (circles) were measured separately and together (squares). Data were
compared to a theoretical molar ellipticity spectrum with no conformational
change (diamonds) calculated for the mixture by averaging the individual spectra of
the two proteins. CD analysis was performed to determine secondary structure
parameters using CDPro (see Section 2). (B) Percent regular, distorted and total a-
helix. (C) Percent regular, distorted, and total b-strand. (D) Percent turns and
unordered secondary structure. ⁄P < 0.05 vs. HNF4a, @P < 0.05 vs. L-FABP, $P < 0.05
vs. [HNF4a + L-FABP] experimental.3.3. L-FABP/HNF4a interaction in vivo: confocal immunoﬂuorescence
FRET imaging in rat T-7 hepatoma cells
T-7 cells were ﬁxed, labeled with Cy3-anti-HNF4a and
Cy5-anti-L-FABP, and imaged by LSCM. First, Cy3-anti-HNF4a was
excited at 567 nm and emission detected through HQ598/40 nm
ﬁlter (Fig. 3A) while Cy5-anti-L-FABP was excited at 647 nm and
emission detected through D680/30 nm ﬁlter (Fig. 3B). Superposi-
tion revealed signiﬁcant colocalization as shown by the yellow pix-
els in the merged image (Fig. 3C) and a ﬂuorogram (Fig. 3D). Since
resolution of LSCM (200 nm) is not high enough to determine if
the two proteins interacted at the molecular level (0–10 nm), FRET
experiments were performed. First, the gain and black levels of the
red channel photomultipliers were set so that there was no pres-
ence of Cy3-HNF4a emission in the D680/30 nm detection (red)
channel (Fig. 3E) using only Cy3-HNF4a immunolabeled cells. Sub-
sequently, in cells double immunolabeled with both Cy3-HNF4a
and Cy5-L-FABP, excitation at 568 nm yielded sensitized emission
that was detected in the Cy5-L-FABP emission channel using the
D680/30 nm ﬁlter (Fig. 3F)—indicating L-FABP in close proximity
to HNFa for binding—consistent with data using puriﬁed proteins
(Fig. 1, Table 1).3.4. Effect of L-FABP expression on HNF4a transactivation
To determine if L-FABP/HNF4a interaction is functionally signif-
icant, a transactivation assay was performed. Control and L-FABP
Fig. 3. Immunoﬂuorescence LSCM and FRET between double immunolabeled
L-FABP/HNF4a in T-7 rat hepatoma cells. T-7 cells were labeled with Cy3-anti-HNF4a
and Cy5-anti-L-FABP for LCSM imaging as in Methods. (A) Cy3-HNF4a, excited at
567 nm, was detected with a HQ598/40 nm ﬁlter and pseudo-colored green (green).
(B) Cy5-L-FABP, excited at 647 nm, was detected using a D680/30 nm ﬁlter and
pseudo-colored red. (C) Merged imaged of (A) and (B) showing the colocalization
(yellow) of Cy3-HNF4a and Cy5-L-FABP. (D) Fluorogram of (C) with colocalization
coefﬁcients Cred = 1.00 and Cgreen = 0.65. (E) The absence of Cy3-HNF4a emission
through the D680/30 nm ﬁlter (red) is shown as a control. (F) Cy5-L-FABP sensitized
emission (Cy3-HNF4a excited at 567 nm) was detected with D680/30 nm ﬁlter
(red).
Fig. 4. Effect of L-FABP expression on HNF4a transactivation activity of ApoB. Control an
and reporter plasmid as in Methods. Cells were incubated with serum free medium for 2
CoA, or arachidonic acid overnight and then assayed. The resulting transactivation dat
activity and corrected for the effect of the empty pLEN4 vector (B), with the L-FABP bez
respectively.
3790 A.L. McIntosh et al. / FEBS Letters 587 (2013) 3787–3791overexpressing COS-7 cells transfected with an apoB reporter plas-
mid and either HNF4a or empty vector were incubated overnight
with BSA or BSA complexed with bezaﬁbrate, palmitic acid, bro-
mo-palmitate, C16:0-S-S-CoA, or arachidonic acid as in Methods.
The luciferase activity of the apoB reporter plasmid resulting from
HNF4a transactivation (not shown) was corrected by normaliza-
tion to the internal control (Renilla luciferase) activity and cor-
rected for the effect of the empty pLEN4 vector (Fig. 4B) with the
L-FABP bezaﬁbrate sample arbitrarily set to 100% (Fig. 4A). The
control (transfection using empty pLEN4 vector) revealed only
slight activity with no signiﬁcant response to any of the lipid incu-
bations and/or overexpression of L-FABP (Fig. 4B). However, in
HNF4a transfected cells L-FABP overexpression signiﬁcantly en-
hanced (corrected for the controls) HNF4a-mediated activation of
ApoB transcription in the presence of each of the lipids (Fig. 4A);
the largest response obtained with bromo-palmitate and non-
metabolizable C16:0-S-S-CoA.
4. Discussion
HNF4a, a member of the steroid hormone receptor superfamily,
is involved in regulating hepatocyte lipid and carbohydrate
metabolic genes [4,16]. Signiﬁcant evidence suggests HNF4a binds
and may be activated by lipidic ligands such as long chain fatty
acids LCFA/LCFA-CoA [14,17–22] and xenobiotics [18,20,21,23,24].
Importantly, linoleic acid has been observed natively bound to
HNF4a from mouse liver [25]. Missense mutations in HNF4a,
speciﬁcally the ligand binding domain, lead to a loss-of-function
and result in the maturity onset diabetes of the young (MODY 1)
[26]. In certain mutations, ligand binding afﬁnities are decreased
resulting in failure of transactivation [14]. Interestingly, HNF4a
itself controls hepatic expression of the cytosolic LCFA/LCFA-CoA
binding proteins L-FABP and ACBP [1–4,27]—both contributing to
uptake, intracellular transport, and nuclear targeting of these
ligands [28,29]. In a positive feed-back loop, ACBP has been
shown to directly bind and activate HNF4a transcriptional activity
[5]. The key question of whether L-FABP likewise binds and
activates HNFa was the focus of the current investigation.
The data presented herein were consistent with the hypothesis
that L-FABP also physically and functionally interacts with HNF4a.
L-FABP/HNF4a interaction was shown by a FRET binding assay, CD,
as well as immunoﬂuorescence LSCM and FRET. Furthermore,
L-FABP overexpression enhanced the HNF4a transcriptional activityd L-FABP overexpressing COS-7 cells were transfected with HNF4a or empty vector,
h. prior to adding 10 lM of bezaﬁbrate, palmitic acid, bromo-palmitate, C16:0-S-S-
a (A) were presented as ﬁreﬂy luciferase activity normalized to Renilla luciferase
aﬁbrate sample arbitrarily set to 100%. # refer to P < 0.05 for L-FABP – vs. L-FABP+,
A.L. McIntosh et al. / FEBS Letters 587 (2013) 3787–3791 3791of an apoB reporter plasmid in the absence of exogenous ligand
and, even more so, in the presence of metabolizable and
non-metabolizable LCFAs and LCFA-CoAs as well as peroxisome
proliferators (i.e. bezaﬁbrate) in COS-7 cells. All these ligands are
bound by L-FABP. L-FABP may facilitate lipidic ligand mediated
activation by enhancing ligand uptake and/or mediating bound
ligand delivery to HNF4a for direct transfer upon L-FABP/HNF4a
interaction. In the latter mechanism, L-FABP would provide a
signaling path to HNF4a analogous to its ability to facilitate ligand
activated transcriptional activity of PPARa [10–12,29]. Taken to-
gether, these ﬁndings suggest that L-FABP may effectively act as
a coregulator of both HNF4a and PPARa targeted gene transcrip-
tion, both of whose response elements are present in the L-FABP
promoter [30].
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